Rainbow Children's Medicare Limited (NSE:RAINBOW)
1,369.40
-11.00 (-0.80%)
Oct 31, 2025, 3:30 PM IST
NSE:RAINBOW Revenue
Rainbow Children's Medicare had revenue of 3.53B INR in the quarter ending June 30, 2025, with 6.88% growth. This brings the company's revenue in the last twelve months to 15.39B, up 14.82% year-over-year. In the fiscal year ending March 31, 2025, Rainbow Children's Medicare had annual revenue of 15.16B with 16.88% growth.
Revenue (ttm)
15.39B
Revenue Growth
+14.82%
P/S Ratio
9.04
Revenue / Employee
3.87M
Employees
3,972
Market Cap
139.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 15.16B | 2.19B | 16.88% |
| Mar 31, 2024 | 12.97B | 1.23B | 10.51% |
| Mar 31, 2023 | 11.74B | 2.00B | 20.52% |
| Mar 31, 2022 | 9.74B | 3.24B | 49.80% |
| Mar 31, 2021 | 6.50B | -693.44M | -9.64% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 282.46B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |